Cassava Sciences Inc
SAVA

About Cassava Science
Cassava Sciences, Inc. (NASDAQ: SAVA) is a clinical-stage biotechnology company focused on developing drugs for neurodegenerative diseases, particularly Alzheimer's disease. Due to its significant potential impact, SAVA's stock price is highly volatile and attractive to speculative investors in the biotech sector.
FAQ
You can easily purchase Cassava Science (SAVA) shares through the Gotrade app. Simply download the app, set up your account, fund it, and then search for the 'SAVA' ticker to begin your investment journey.
At Gotrade, you can kickstart your investment in Cassava Science with as little as $1.
Absolutely. Brokerage services on Gotrade Indonesia are provided by PT Valbury Asia Futures, a licensed futures and commodities broker registered with and supervised by the Indonesian Financial Services Authority (OJK).
Yes. Gotrade provides access to U.S. stocks from Indonesia through fully backed shares. This is facilitated through a cross-border order routing scheme for foreign stock derivative contracts (PALN), in accordance with regulations from Bappebti (the Commodity Futures Trading Regulatory Agency).
When you trade, you enter into a contract with PT Valbury Asia Futures (Valbury), a Bappebti-registered broker in Indonesia. Valbury, in turn, fully backs its contracts 1-for-1 with Alpaca Securities LLC, a FINRA-licensed broker-dealer in the United States. For every share (or fraction thereof) you hold on Gotrade, a corresponding share is held by Valbury in a separate, segregated brokerage account at Alpaca Securities LLC.
Buy SAVA stock
View SAVA stock price and Buy/Sell SAVA. See news, trading signals, analyst predictions, and more in the app.
